E-LIB Suche - Ergebnisse für: Schwabl, P.

1

Animal models of portal hypertension:

Königshofer, P. ; Brusilovskaya, K. ; Schwabl, P..
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865 (2019) 5 - p. 1019-1030 , 2019

Link: https://doi.org/10.1016/..

2

The impact of hepatic steatosis on portal hypertension:

Scheiner, B. ; Semmler, G. ; Schwabl, P....
Journal of Hepatology. 68 (2018) - p. S707 , 2018

Link: https://doi.org/10.1016/..

3

Controlled attenuation parameter does not predict hepatic d..:

Scheiner, B. ; Steininger, L. ; Semmler, G....
Journal of Hepatology. 68 (2018) - p. S707-S708 , 2018

Link: https://doi.org/10.1016/..

4

Resolution of clinically significant portal hypertension af..:

Mandorfer, M. ; Kozbial, K. ; Schwabl, P....
Journal of Hepatology. 68 (2018) - p. S532 , 2018

Link: https://doi.org/10.1016/..

5

Effect of vardenafil on portal hemodynamics in patients wit..:

Paternostro, R. ; Heinisch, B. ; Schwarzer, R....
Journal of Hepatology. 68 (2018) - p. S717 , 2018

Link: https://doi.org/10.1016/..

6

Impact of SVR to IFN-free DAA therapy on steatosis in HIV/H..:

Chromy, D. ; Schwabl, P. ; Bucsics, T....
Journal of Hepatology. 68 (2018) - p. S548 , 2018

Link: https://doi.org/10.1016/..

7

Effectiveness of "early" TIPS implantation versus "late" TI..:

Bucsics, T. ; Schoder, M. ; Mandorfer, M....
Journal of Hepatology. 68 (2018) - p. S694-S695 , 2018

Link: https://doi.org/10.1016/..

8

Impact of patatin‐like phospholipase domain containing 3 rs..:

Mandorfer, M. ; Scheiner, B. ; Stättermayer, A. F....
Alimentary Pharmacology & Therapeutics. 48 (2018) 4 - p. 451-459 , 2018

Link: https://doi.org/10.1111/..

9

Betablockers do not increase efficacy of band ligation in p..:

Pfisterer, N. ; Dexheimer, C. ; Fuchs, E.‐M....
Alimentary Pharmacology & Therapeutics. 47 (2018) 7 - p. 966-979 , 2018

Link: https://doi.org/10.1111/..

10

Targeting the nitric-oxide downstream pathway in bile-duct ..:

Brusilovskaya, K. ; Königshofer, P. ; Lampach, D....
Journal of Hepatology. 68 (2018) - p. S9 , 2018

Link: https://doi.org/10.1016/..

11

Prevalence and resistance rates of infections with enteroco..:

Bucsics, T. ; Emich, M. ; Nackenhorst, M.-C....
Journal of Hepatology. 68 (2018) - p. S694 , 2018

Link: https://doi.org/10.1016/..

12

High efficacy of IFN-free DAA therapy for acute HCV infecti..:

Chromy, D. ; Mandorfer, M. ; Bucsics, T....
Journal of Hepatology. 68 (2018) - p. S273 , 2018

Link: https://doi.org/10.1016/..

13

The FXR agonist GS-9674 reduces fibrosis and portal hyperte..:

Schwabl, P. ; Budas, G. ; Hambruch, E....
Journal of Hepatology. 68 (2018) - p. S471-S472 , 2018

Link: https://doi.org/10.1016/..

14

The beneficial effects of non-selective betabockers in seco..:

Pfisterer, N. ; Dexheimer, C. ; Fuchs, E.-M....
Journal of Hepatology. 68 (2018) - p. S730-S731 , 2018

Link: https://doi.org/10.1016/..

15

Outcome after the use of SX-ELLA Danis bleeding stents for ..:

Pfisterer, N. ; Dolak, W. ; Pachofszky, T....
Journal of Hepatology. 68 (2018) - p. S729-S730 , 2018

Link: https://doi.org/10.1016/..